Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Very funny! I’m trying to wean myself of the cy

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154159
(Total Views: 377)
Posted On: 07/04/2019 6:36:51 PM
Avatar
Posted By: trding
Re: Fortuno #4535
Very funny! I’m trying to wean myself of the cydy board on iHub. I’m okay with shareholders complaining, they have earned the right, but I don’t like non-shareholders who clearly follow every word going out of the company but then try to convince shareholders it is going to fail. They wouldn’t waste their time if they really thought that; just trying to pick up cheap shares. Let me guess, this person is calling for 30c.
Also, I guess the next username to pop up will be Johann Sebastian.

On a note on the md recruiting for the tnbc clinical trial. Read her bio to see if you think this person would have a sense of urgency.

Milana V. Dolezal, M.D., M.Sci

"My passion for cancer research started as a teenager working at the National Cancer Institute, NIH in Bethesda, MD where I am from. My compassion for people with cancer came from taking care of my Grandma who helped raise me and died from metastatic breast cancer in our home. Through training at UCLA and then clinical trial work at Genentech, I've witnessed the translation of targeted cancer therapies from bench to bedside. I was fortunate enough to ride my bike across the USA to promote patient participation in clinical trials which help develop new treatments. I provide personalized care by targeting the tumor biology and working with patient and their support team to find the best treatment. I believe in a multidisciplinary approach, including clinical trials if appropriate, and tumor board review. My special interests include women's malignancies and cancer survivorship. Courage and hope exist in all of us: the patient's determination and full participation is crucial".


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us